Publication | Closed Access

Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer–doxorubicin conjugates to human colon cancer cells

NanomedicineMultivalent Galactoside LigandDrug TargetingNanotherapeuticsEngineeringPolymer-drug ConjugateMedicineSelective TargetingTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyHpma Copolymer–doxorubicin ConjugatesCancer ResearchBiomolecular Engineering